1 results match your criteria: "University College London Hospitals Biomedical Research Centre. Electronic address: chunglim@nhs.net.[Affiliation]"
Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations.
J Vasc Surg
May 2021
Royal Free Vascular Malformation Service, Department of Vascular Surgery, Royal Free London NHS Foundation Trust, London, United Kingdom; Division of Surgery and Interventional Science, Department of Surgical Biotechnology, Faculty of Medical Sciences, University College London, London, United Kingdom; National Institute for Health Research, University College London Hospitals Biomedical Research Centre. Electronic address:
Objective: Embolo-sclerotherapy (EST) is the mainstay therapy for peripheral vascular malformations that involves the exposure of patients to ionizing radiation. We analyzed the radiation exposure to patients from EST of peripheral vascular malformations during a 5-year period in a single specialist center.
Methods: All patients who had undergone EST at a single specialist center for peripheral vascular malformations from January 1, 2013 to January 8, 2018 were identified from a prospectively collected database.